Evidence map›Paper›PMID 36012204›Full record

ArticleInternational journal of molecular sciences2022

Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters.

Benoît Chevalier, Nesrine Baatallah, Matthieu Najm, Solène Castanier, Vincent Jung, Iwona Pranke, Anita Golec, Véronique Stoven, Stefano Marullo, Fabrice Antigny and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional Consequences of CFTR Interactions in Cystic Fibrosis.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Benoît ChevalierINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Nesrine BaatallahINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Matthieu NajmCenter for Computational Biology, Mines Paris-PSL, PSL Research University, 75006 Paris, France.ORCID 0000-0001-9757-1499
Solène CastanierINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Vincent JungINSERM US24/CNRS UAR3633, Proteomic Platform Necker, Universit Paris Cité-Federative Research Structure Necker, 75015 Paris, France.ORCID 0000-0003-0530-1737
Iwona PrankeINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Anita GolecINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.ORCID 0000-0001-5039-3568
Véronique StovenCenter for Computational Biology, Mines Paris-PSL, PSL Research University, 75006 Paris, France.ORCID 0000-0003-0828-0759
Stefano MarulloInstitut Cochin, Université Paris Cité, INSERM, U1016, CNRS UMR 8104, 75014 Paris, France.ORCID 0000-0001-9604-9973
Fabrice AntignyFaculté de Médecine, Université Paris-Saclay, 94210 Le Kremlin-Bicêtre, France.ORCID 0000-0002-9515-6571
Ida Chiara GuerreraINSERM US24/CNRS UAR3633, Proteomic Platform Necker, Universit Paris Cité-Federative Research Structure Necker, 75015 Paris, France.ORCID 0000-0002-4832-6793
Isabelle Sermet-GaudelusINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Aleksander EdelmanINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Alexandre HinzpeterINSERM, U1151, Institut Necker-Enfants Malades, 75015 Paris, France.
Centre National de la Recherche Scientifique · FRInserm · FRHôpital Necker-Enfants Malades · FR

Funding

Agence Nationale de la Recherche ANR-18-CE14-0004-02Association Mucoviscidose - ABCF2Association pour l'Aide à la Recherche contre la Mucoviscidose (AARM)Fondation Dassault SystemsVaincre la Mucoviscidose RF20190502488Vaincre la Mucoviscidose RF20210502867
6 · The paper itself

Abstract

Proteins interacting with CFTR and its mutants have been intensively studied using different experimental approaches. These studies provided information on the cellular processes leading to proper protein folding, routing to the plasma membrane, recycling, activation and degradation. Recently, new approaches have been developed based on the proximity labeling of protein partners or proteins in close vicinity and their subsequent identification by mass spectrometry. In this study, we evaluated TurboID- and APEX2-based proximity labeling of WT CFTR and compared the obtained data to those reported in databases. The CFTR-WT interactome was then compared to that of two CFTR (G551D and W1282X) mutants and the structurally unrelated potassium channel KCNK3. The two proximity labeling approaches identified both known and additional CFTR protein partners, including multiple SLC transporters. Proximity labeling approaches provided a more comprehensive picture of the CFTR interactome and improved our knowledge of the CFTR environment.

Indexed as

Cystic Fibrosis Transmembrane Conductance RegulatorProtein FoldingCell MembraneMass SpectrometryMutationCystic Fibrosis Transmembrane Conductance RegulatorCFTRcystic fibrosisinteractomeKCNK3proximity labelingSLC transporters

Identifiers

PMID36012204
PMCPMC9408702
OpenAlexW4291016379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.